Our Journey and Mission
Our Experts
Join Our Journey
Max Taouil
President North America
Brings over 25 years of global executive experience across biotechnology, natural supplements, and technology industries. In his role, he leads the development and commercialization of cutting-edge health supplements designed for the U.S. market, with a strategic focus on innovation, regulatory compliance, and market expansion.
In former multinationals, he demonstrated exceptional leadership by overseeing funding and development of ventures across four continents—managing budgets ranging from $500,000 to over $100 million. Armed with an MBA from Webster University and dual Bachelor’s degrees in Chemistry and Mathematics from Park University, Max combines scientific expertise with proven entrepreneurial execution. He is passionate about Longevity and Quality of Life health initiatives.
Almero Bourbon
Founder – Group CEO
He brings three+ decades of global executive leadership and expertise to Ænigma Biosciences as co-founder. Combining his deep experiential scientific knowledge, proven execution, drives the breakthrough innovations in bio-pharma technology. His diversification in AI-driven bioscience diagnostics coupled with bio-actives and phytochemistry expertise, primarily drove the revolutionizing of drug solubility and bioavailability challenges. This interdisciplinary approach with a particular depth in cannabinoids, terpenoids, flavonoids, and natural bio-actives combined with his systems approach enables the design and validation of synergistic formulations that directly address the industry’s most persistent challenge – 90% of pipeline drugs, plagued by poor solubility and absorption. The ability to integrate complex technologies into scalable solutions, architecting multi-channel commercialization strategies, successfully translate into cutting-edge scientific breakthroughs and market-ready innovations. This combination of scientific depth, systems thinking, and commercial acumen makes him a transformative leader at the intersection of nanotechnology, biosciences, and pharmaceutical innovation.
Dr. Priyamvada Pradeep
Lead Formulation Scientist
Pharmacist with Masters of Science in Medicinal Chemistry and PhD in Organic Chemistry Her research encompasses: Synthetic Organic Chemistry: Multistep synthesis of organic molecules, Medicinal Chemistry: Investigation of therapeutic molecules and reaction mechanisms, In Silico Screening: Generation of therapeutic molecules through computational methods, Biomaterials Synthesis: Advanced material design for pharmaceutical applications, Drug Delivery Systems: Development of novel delivery platforms. She has extensive experience in preformulation /formulation development.
